RO1138452 10mg | ≥97%
CSNpharm
RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.
More Information Supplier Page
RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.
More Information Supplier PageLMPTP INHIBITOR 1 2HCl is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
More Information Supplier Page
Carbidopa Monohydrate is a decarboxylase inhibitor, can be used in combination with levodopa for treatment of Parkinsonism.
More Information Supplier Page
Carbidopa Monohydrate is a decarboxylase inhibitor, can be used in combination with levodopa for treatment of Parkinsonism.
More Information Supplier PageLMPTP INHIBITOR 1 2HCl is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
More Information Supplier PageLMPTP INHIBITOR 1 2HCl is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
More Information Supplier PageLMPTP INHIBITOR 1 2HCl is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
More Information Supplier PageLMPTP INHIBITOR 1 2HCl is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
More Information Supplier Page
Dabigatran etexilate mesylate is the orally active prodrug of dabigatran, a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
More Information Supplier Page
Dabigatran etexilate mesylate is the orally active prodrug of dabigatran, a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
More Information Supplier Page